Plant Summary
Plant Information
TCMBank_ID: | TCMBANKHE004261 |
YEM_ID: | YEM-404 |
YNS_ID: | YNS-302 |
XU_ID: | XU-755 |
ID: | TCMBANKHE004261/YNS-302/YEM-404/XU-755 |
植物拉丁名: |
|
功能与主治: | 解毒消肿，收敛止血，杀菌去腐，用于痈肿，疳疔疮毒，阴囊湿疹，外伤出血，跌打损伤，蛇虫叮咬。|To relieve cough and transform phlegm, engender liquid and allay thirst, resolve toxin./Common cold with fever, cough, throat pain, diphtheria, enteritis, diarrhea, eczema, heat vexation and thirst. |
药用植物名: | 庵摩勒|余甘子 |
药名: | 余甘子树皮|滇橄榄 |
来源: | 云南药材标准：第三册|云南民族药物志：第二卷|广东省廉江市石岭镇 |
药用部位: | fruit|树皮|茎 |
使用民族: | 阿昌族/白族/布朗族/傣族/哈尼族/基诺族/拉祜族/傈僳族/纳西族/普米族/佤族/瑶族/彝族/藏族/壮族 |
科: | 大戟科 |
属: | 叶下珠属 |
KUMST_ID1: | KMUST-BS-0768 |
KUMST_ID2: | KMUST-202404140001-1 |
TCM_ID_id: | 1826 |
植物对应的化合物
| 化合物ID | 化合物名 | 别名 | 分子式 | 分子质量 | Smiles |
|---|
| TCMBANKIN000277 | 3′, 6′-di-O-galloylpaeoniflorin | ||||
| TCMBANKIN001449 | 2,6-dimethoxy-4-(2-hydroxyethyl)phenol 1-O-beta-D-glucopyranoside_qt | 198.24 | |||
| TCMBANKIN001783 | mucicacid 2-o-gallate | C13H14O12 | C1=C(C=C(C(=C1O)O)O)C(=O)OC(C(C(C(C(=O)O)O)O)O)C(=O)O | ||
| TCMBANKIN001891 | mucicacid 1,4-lactone 3-o-gallate | C13H12O11 | C1=C(C=C(C(=C1O)O)O)C(=O)OC2C(C(=O)OC2C(C(=O)O)O)O | ||
| TCMBANKIN003457 | mucicacid 1,4-lactone 3,5-di-o-gallate | C20H16O15 | C1=C(C=C(C(=C1O)O)O)C(=O)OC2C(C(=O)OC2C(C(=O)O)OC(=O)C3=CC(=C(C(=C3)O)O)O)O | ||
| TCMBANKIN004275 | phyllaemblicacid b | C15H24O9 | 348.34 g/mol | C1C(CC2C(C1O)C(C3(O2)CC(C(CO3)CO)O)(CO)O)C(=O)O | |
| TCMBANKIN005080 | neochebulagicacid | C41H32O28 | C1C2C(C(C(C(O2)OC(=O)C3=CC(=C(C(=C3)O)O)O)O)OC(=O)C4=CC(=C(C(=C4C5=C(C(=C(C=C5C(=O)O1)O)O)O)O)O)O)OC(=O)C(CC(=O)O)C6C(OC(=O)C7=CC(=C(C(=C67)O)O)O)C(=O)O | ||
| TCMBANKIN011763 | mucicacid 1,4-lactone methyl ester 5-o-gallate | C14H14O11 | COC(=O)C(C1C(C(C(=O)O1)O)O)OC(=O)C2=CC(=C(C(=C2)O)O)O | ||
| TCMBANKIN012548 | 2,3-o-(s)-hexahydroxydiphenoyl-d-gluco-pyranose | C20H18O14 | 482.3 g/mol | C1=C2C(=C(C(=C1O)O)O)C3=C(C(=C(C=C3C(=O)OC4C(C(C(OC4O)CO)O)OC2=O)O)O)O | |
| TCMBANKIN013509 | l-malicacid 2-o-gallate | C11H10O9 | C1=C(C=C(C(=C1O)O)O)C(=O)OC(CC(=O)O)C(=O)O | ||
| TCMBANKIN013511 | chebulagic acid | chebulagic acid ; chebulagicacid; Chebulagic acid | C41H30O27 | 954.66 | C1C2C3C(C(C(O2)OC(=O)C4=CC(=C(C(=C4)O)O)O)OC(=O)C5=CC(=C(C6=C5C(C(C(=O)O3)CC(=O)O)C(C(=O)O6)O)O)O)OC(=O)C7=CC(=C(C(=C7C8=C(C(=C(C=C8C(=O)O1)O)O)O)O)O)O |
| TCMBANKIN014270 | Cheilanthifoline | cheilanthifoline; CHEMBL1209678; cheilanthifolin(e); Chelianthifoline | C19H19NO4 | 325.36 | COC1=C(C=C2C3CC4=C(CN3CCC2=C1)C5=C(C=C4)OCO5)O |
| TCMBANKIN016255 | mucicacid dimethyl ester 2-o-gallate | C15H18O12 | COC(=O)C(C(C(C(C(=O)OC)OC(=O)C1=CC(=C(C(=C1)O)O)O)O)O)O | ||
| TCMBANKIN019504 | phyllaemblicacid c | C15H24O8 | 332.35 g/mol | C1CC2C(CC1C(=O)O)OC3(C2(CO)O)CC(C(CO3)CO)O | |
| TCMBANKIN025591 | mucicacid 1,4-lactone methyl ester 2-o-gallate | C14H14O11 | COC(=O)C(C1C(C(C(=O)O1)OC(=O)C2=CC(=C(C(=C2)O)O)O)O)O | ||
| TCMBANKIN026501 | mucicacid 1,4-lactone 5-o-gallate | C13H12O11 | C1=C(C=C(C(=C1O)O)O)C(=O)OC(C2C(C(C(=O)O2)O)O)C(=O)O | ||
| TCMBANKIN027838 | Lupeol acetate | lupeol acetate; 3-Acetyllupeol; Acetic acid (1R,3aR,4S,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-1-isopropenyl-3a,5a,5b,8,8,11a-hexamethyl-eicosahydro-cyclopenta[a]chrysen-9-yl ester; C08630; AIDS-076591; Lup-20(29)-en-3-ol, acetate, (3beta)-; LMPR01060014; AIDS076591; Lup-20(29)-en-3beta-ol, acetate (8CI); NSC 281806; 1617-68-1; EINECS 216-575-8 | C32H52O2 | 468.75 | CC(=C)C1CCC2(C1C3CCC4C5(CCC(C(C5CCC4(C3(CC2)C)C)(C)C)OC(=O)C)C)C |
| TCMBANKIN029647 | putrescine | 2-Butynedinitrile; Spectrum2_001935; NSC5861; Tetramethyldiamine; PUTRESCINE; KBio2_007262; Lopac-P-7505; AC1NS0M0; KBio2_004694; Sous-azote de carbone [French]; 1,4-Diamino-n-butane; NCGC00015837-01; SCHEMBL313163; CHEMBL1255652; KBio1_000716; 2-Butynedinitrile (9CI); InChI=1/C4H12N2/c5-3-1-2-4-6/h1-6H; ACETYLENEDICARBONITRILE; PUT; 32791_FLUKA; NINDS_000716; Spectrum_001646; KBio3_002375; Putrescin; BSPBio_002875; 4-aminobutylamine; D13208_ALDRICH; 333-93-7 (DIHYDROCHLORIDE); ZERO/005579; 1,4-butanediamine; .alpha.,.omega.-Butanediamine; Putreszin; A821757; CCRIS 6751; Spectrum3_001198; SDCCGMLS-0066929.P001; ZINC02039983; AI3-25444; Lopac0_000972; AIDS081098; 1071-98-3; 1,4-diaminobutane; but-2-ynedinitrile; VZ34178; Dicyanoacetylene; H2N(CH2)4NH2; Dicyanoethyne; IDI1_000716; butane-1,4-diamine; Butylenediamine; NCGC00180885-01; BRN 0605282; 32790_FLUKA; 4-04-00-01283 (Beilstein Handbook Reference); BUTANE,1,4-DIAMINO; KBioSS_002126; butane-1,4-diamine hydrochloride; KBioGR_000933; 1,4-Butylenediamine; 1,4-Tetramethylenediamine; Spectrum5_001005; CHEBI:17148; NSC-5861; SPBio_001969; NSC60545; alpha,omega-Diamine; KBio2_002126; C02896; 110-60-1; C00134; tetramethylenediamine; AIDS-081098; DivK1c_000716; Spectrum4_000237; EINECS 203-782-3; NCI60_004431; BRN 1735267; NSC 60545 | C4N2 | 76.06 | C(CCN)CN |
| TCMBANKIN031814 | 2-carboxymethyl-3-phenyl-2,3-epoxy-1,4-naph-thoquinone | C17H16O5 | CC(=CCC12C(=O)C3=CC=CC=C3C(=O)C1(O2)C(=O)OC)C | ||
| TCMBANKIN033227 | mucicacid 1,4-lactone 2-o-gallate | C13H12O11 | C1=C(C=C(C(=C1O)O)O)C(=O)OC2C(C(OC2=O)C(C(=O)O)O)O | ||
| TCMBANKIN034136 | mucronatinine | C19H27NO5 | 349.4 g/mol | CCC1(C(CC(=CC)C(=O)OC2CCN3C2C(=CC3)COC1=O)C)O | |
| TCMBANKIN036050 | (?)-epicatechin | C15H14O6 | |||
| TCMBANKIN036900 | corilagin | Corilagin; C10219; .beta.-D-Glucopyranose, cyclic 3,6-[(1R)-(4,4',5,5',6,6'-hexahydroxy[1,1'-biphenyl]-2,2'-dicarboxylate] 1-(3,4,5-trihydroxybenzoate); 23094-69-1; AIDS-025842; beta-D-Glucopyranose, cyclic 3,6-(4,4',5,5',6,6'-hexahydroxy(1,1'-biphenyl)-2,2'-dicarboxylate) 1-(3,4,5-trihydroxybenzoate), (R)-; AIDS025842; corilagin | C27H24O17 | 620.469 | c1(O[H])c(c(c(C([H])=O)c([H])c(O[H])c2O[H])c2O[H])c([H])c(C(OC([H])([H])[C@@]3([H])O[C@@]([H])(OC(c4c([H])c(O[H])c(O[H])c(O[H])c4[H])=O)[C@]([H])(O[H])C([H])([H])[C@]3([H])O[H])=O)c(O[H])c1O[H] |
| TCMBANKIN037410 | 1-O-Galloyl-glycerol | glycerol gallate; 2,3-dihydroxypropyl 3,4,5-trihydroxybenzoate; SCHEMBL1392652; AC1NSVMV; NP-011847; 1-o-galloylglycerol; 59634-75-2; 1-o-galloyl-glycerol | C10H12O7 | 244.2 g/mol | C1=C(C=C(C(=C1O)O)O)C(=O)OCC(CO)O |
| TCMBANKIN037528 | mucic acid | CHEBI:16537; DSLZVSRJTYRBFB-DUHBMQHGSA-L; mucicacid; meso-galactarate; galactarate; D-galactarate; mucate; (2S,3R,4S,5R)-2,3,4,5-tetrahydroxyhexanedioate; galactarate(2-); AC1NUSG1; (2R,3S,4R,5S)-2,3,4,5-tetrahydroxyhexanedioate | C6H8O8-2 | 208.12 g/mol | C(C(C(C(=O)[O-])O)O)(C(C(=O)[O-])O)O |
| TCMBANKIN041689 | furosin | furosin | C27H22O19 | 650.45 | C1=C(C=C(C(=C1O)O)O)C(=O)OC2C3C(C(C(O2)CO)OC(=O)C4=CC(=O)C(C5(C4C6=C(O5)C(=C(C=C6C(=O)O3)O)O)O)(O)O)O |
| TCMBANKIN041852 | Phyllanemblinin C | phyllanemblinin c | 970.7 g/mol | ||
| TCMBANKIN043191 | Phyllanemblinin D | phyllanemblinin d | C27H26O20 | 670.5 g/mol | C1=C(C=C(C(=C1O)O)O)C(=O)OC2C(C(C(C(O2)CO)O)OC(=O)C(CC(=O)O)C3C(OC(=O)C4=CC(=C(C(=C34)O)O)O)C(=O)O)O |
| TCMBANKIN043218 | Elaeocarpusin | elaeocarpusin | 1110.75 | ||
| TCMBANKIN043548 | Phyllanemblinin B | phyllanemblinin b | C27H22O18 | 634.5 g/mol | C1=C(C=C(C(=C1O)O)O)C(=O)OC2C3C(C(C(O2)CO)OC(=O)C4=CC(=C(C(=C4C5=C(C(=C(C=C5C(=O)O3)O)O)O)O)O)O)O |
| TCMBANKIN043568 | 1,4-di-o-galloylglucose | C20H20O14 | C1=C(C=C(C(=C1O)O)O)C(=O)OC2C(OC(C(C2O)O)OC(=O)C3=CC(=C(C(=C3)O)O)O)CO | ||
| TCMBANKIN043849 | Geraniin | AKOS015965424; CHEBI:5328; AC1MHDT3; 60976-49-0; BG01794303; ST24046002; Geraniiin; .beta.-D-Glucopyranose, cyclic 2.fwdarw.7:4.fwdarw.5-(3,6-dihydro-2,9,10,11,11-pentahydroxy-3-oxo-2,6-methano-2H-1-benzoxocin-5,7-dicarboxylate)cyclic 3,6-(4,4',5,5',6,6'-hexahydroxy[1,1'-biphenyl]-2,2'-dicarboxylate) 1-(3,4,5-trihydroxybenzoate), stereoisomer; BDBM50242278; BC216245; Q-100702; ZINC169289506; [undecahydroxy(pentaoxo)[?]yl] 3,4,5-trihydroxybenzoate; AIDS-048857; AC-8425; C10230; D0C6QS; 4CN-2802; .beta.-D-Glucopyranose, cyclic 2.fwdarw.7:4.fwdarw.5-(3,6-dihydro-2,9,10,11,11-pentahydroxy-3-oxo-2,6-methano-2H-1-benzoxocin-5,7-dicarboxylate) cyclic 3,6-(4,4',5,5',6,6'-hexahydroxy[1,1'-biphenyl]-2,2'-dicarboxylate) 1-(3,4,5-trihydroxybenzoate), stereo; Geraniin; AIDS048857; CHEMBL506069; (1R,7R,8S,26R,28S,29R,38R)-1,13,14,15,18,19,20,34,35,39,39-UNDECAHYDROXY-2,5,10,23,31-PENTAOXO-6,9,24,27,30,40-HEXAOXAOCTACYCLO[34.3.1.0?,(3)?.0?,(2)?.0?,(2)?.0(1)(1),(1)?.0(1)?,(2)(2).0(3)(2),(3)?]TETRACONTA-3,11(16),12,14,17(22),18,20,32,34,36-DECAEN-28-YL 3,4,5-TRIHYDROXYBENZOATE; JQQBXPCJFAKSPG-SVYIMCMUSA-N; (1R,7R,8S,26R,28S,29R,38R)-1,13,14,15,18,19,20,34,35,39,39-UNDECAHYDROXY-2,5,10,23,31-PENTAOXO-6,9,24,27,30,40-HEXAOXAOCTACYCLO[34.3.1.0?,(3)?.0?,(2)?.0?,(2)?.0(1)(1),(1)?.0(1)?,(2)(2).0(3)(2),(3)?]TETRACONTA-3,11(16),12,14,17,19,21,32(37),33,35-DECAEN-28-YL 3,4,5-TRIHYDROXYBENZOATE; geraniin | C41H28O27 | 953 | [C@]12([H])[C@]3([H])[C@]([H])(OC(=O)c(c([H])c(O[H])c(O[H])c4O[H])c4c(c(O[H])c(O[H])c(O[H])c5[H])c5C(=O)OC1([H])[H])[C@@]([H])(OC(=O)c(c([H])c(O[H])c6O[H])c(c6O7)[C@@]([H])(C(C(=O)O3)=C([H])C8=O)[C@@] 7(O[H])C8(O[H])O[H])[C@]([H])(OC(=O)c9c([H])c(O[H])c(O[H])c(O[H])c9[H])O2 |
| TCMBANKIN044040 | tercatain | C34H26O22 | 786.56 | C1C2C(C(C(C(O2)OC(=O)C3=CC(=C(C(=C3)O)O)O)O)OC(=O)C4=CC(=C(C(=C4C5=C(C(=C(C=C5C(=O)O1)O)O)O)O)O)O)OC(=O)C6=CC(=C(C(=C6)O)O)O | |
| TCMBANKIN044452 | Chebulanin | 652.47 | |||
| TCMBANKIN044463 | Mallonin | ||||
| TCMBANKIN045221 | prodelphinidin b2 | C30H26O14 | 610.5 g/mol | C1C(C(OC2=C1C(=CC(=C2C3C(C(OC4=CC(=CC(=C34)O)O)C5=CC(=C(C(=C5)O)O)O)O)O)O)C6=CC(=C(C(=C6)O)O)O)O | |
| TCMBANKIN046207 | chebulic acid | chebulicacid | C14H12O11 | 356.24 | C1=C2C(=C(C(=C1O)O)O)C(C(OC2=O)C(=O)O)C(CC(=O)O)C(=O)O |
| TCMBANKIN046337 | Phyllanemblinin A | phyllanemblinin a | 616.4 g/mol | ||
| TCMBANKIN046363 | prodelphinidin b1 | C30H26O14 | 610.5 g/mol | C1C(C(OC2=C1C(=CC(=C2C3C(C(OC4=CC(=CC(=C34)O)O)C5=CC(=C(C(=C5)O)O)O)O)O)O)C6=CC(=C(C(=C6)O)O)O)O | |
| TCMBANKIN047862 | Phyllanemblinin F | phyllanemblinin f | C27H26O20 | 670.5 g/mol | C1=C(C=C(C(=C1O)O)O)C(=O)OC2C(C(C(C(O2)COC(=O)C(CC(=O)O)C3C(OC(=O)C4=CC(=C(C(=C34)O)O)O)C(=O)O)O)O)O |
| TCMBANKIN049074 | Phyllanemblinin E | phyllanemblinin e | 670.5 g/mol | ||
| TCMBANKIN050048 | phyllaemblicin d | C21H34O13 | 494.5 g/mol | C1CC2C(CC1C(=O)O)OC3(C2(CO)O)CC(C(CO3)COC4C(C(C(C(O4)CO)O)O)O)O | |
| TCMBANKIN057933 | coriose;D-Altro-3-heptulose | 1,2,4,5,6,7-hexahydroxyheptan-3-one; AC1NSTTI | C7H14O7 | 210.18 g/mol | C(C(C(C(C(=O)C(CO)O)O)O)O)O |
| TCMBANKIN058063 | 6-O-Galloylglucose | [(2R,3R,4S,5R)-2,3,4,5-tetrahydroxy-6-oxohexyl] 3,4,5-trihydroxybenzoate; 3,4,5-trihydroxybenzoic acid [(2R,3R,4S,5R)-2,3,4,5-tetrahydroxy-6-keto-hexyl] ester; 3,4,5-trihydroxybenzoic acid [(2R,3R,4S,5R)-2,3,4,5-tetrahydroxy-6-oxohexyl] ester; 13186-19-1; D-Glucose, 6-(3,4,5-trihydroxybenzoate); D-Glucose, 6-gallate; 6-O-Galloyl-D-glucose; [(2R,3R,4S,5R)-2,3,4,5-tetrahydroxy-6-oxo-hexyl] 3,4,5-trihydroxybenzoate; 6-o-galloyl-glucose; 6-o-galloyl-d-glucose; D-Glucose,6-(3,4,5-trihydroxybenzoate); 13186-19-1; 6-O-Galloylglucose; CHEMBL1221848; D-Glucose, 6-(3,4,5-trihydroxybenzoate); AC1Q6A7B; 6-O-Galloyl-glucose; CTK4B7571; AC1L2UJB; SCHEMBL3228891; 6-O-Galloyl-D-glucose; (2R,3R,4S,5R)-2,3,4,5-TETRAHYDROXY-6-OXOHEXYL 3,4,5-TRIHYDROXYBENZOATE | C13H16O10 | 332.26 g/mol | C1=C(C=C(C(=C1O)O)O)C(=O)OCC(C(C(C(C=O)O)O)O)O |
| TCMBANKIN058069 | 1,2,3,6-Tetragalloylglucose | [(2S,3R,4S,5R,6R)-5-hydroxy-2,3-bis[(3,4,5-trihydroxyphenyl)carbonyloxy]-6-[(3,4,5-trihydroxyphenyl)carbonyloxymethyl]oxan-4-yl] 3,4,5-trihydroxybenzoate; 79886-50-3; 1,2,3,6-Tetra-O-galloyl-B-D-glucose; 1,2,3,6-Tgg; beta-D-Glucopyranose, 1,2,3,6-tetrakis(3,4,5-trihydroxybenzoate); 1,2,3,6-tetrakis-O-(3,4,5-trihydroxybenzoyl)-beta-D-glucopyranose; 3,4,5-trihydroxybenzoic acid [(2S,3R,4S,5R,6R)-5-hydroxy-2,3-bis[oxo-(3,4,5-trihydroxyphenyl)methoxy]-6-[[oxo-(3,4,5-trihydroxyphenyl)methoxy]methyl]-4-tetrahydropyranyl] ester; AIDS-070890; 1,2,3,6-Tetra-O-galloyl-beta-D-glucose; [(2S,3R,4S,5R,6R)-5-hydroxy-2,3-bis[(3,4,5-trihydroxybenzoyl)oxy]-6-[(3,4,5-trihydroxybenzoyl)oxymethyl]tetrahydropyran-4-yl] 3,4,5-trihydroxybenzoate; MEGxp0_001175; CHEBI:17527; AIDS070890; [(2S,3R,4S,5R,6R)-5-hydroxy-2,3-bis[(3,4,5-trihydroxybenzoyl)oxy]-6-[(3,4,5-trihydroxybenzoyl)oxymethyl]oxan-4-yl] 3,4,5-trihydroxybenzoate; 3,4,5-trihydroxybenzoic acid [(2S,3R,4S,5R,6R)-5-hydroxy-2,3-bis[(3,4,5-trihydroxybenzoyl)oxy]-6-[(3,4,5-trihydroxybenzoyl)oxymethyl]tetrahydropyran-4-yl] ester; C04516; 1,2,3,6-Tetrakis-O-galloyl-beta-D-glucose; ACon1_000379; 1,2,3,6-tetragalloylglucose; 1,2,3,6-tetra-O-galloyl-β-D-glucose; 1,2,3,6-tetra-O-galloyl-β-D-glucopyranose; 1,2,3,6-Tetragalloylglucose; 1,2,3,6-tetra-o-galloyl-beta-d-glucopyranoside; 1,2,3,6-tetra-o-galloyl-beta-d-glucose; 1,2,3,6-tetra-o-galloyl-β-d-glucose; 1, 2, 3, 6-tetra-o-galloyl-beta-d-glucopyranoside | C34H28O22 | 788.6 g/mol | C1=C(C=C(C(=C1O)O)O)C(=O)OCC2C(C(C(C(O2)OC(=O)C3=CC(=C(C(=C3)O)O)O)OC(=O)C4=CC(=C(C(=C4)O)O)O)OC(=O)C5=CC(=C(C(=C5)O)O)O)O |
| TCMBANKIN058071 | gallic acid 3- o -(6-galloylglucoside) | Gallic acid-3-O-(6'-O-galloyl)glucoside; gallic acid-3-O-(6'-O-galloyl)-glucoside; 3,4-dihydroxy-5-[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[oxo-(3,4,5-trihydroxyphenyl)methoxy]methyl]-2-tetrahydropyranyl]oxy]benzoic acid; 3,4-dihydroxy-5-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[(3,4,5-trihydroxybenzoyl)oxymethyl]tetrahydropyran-2-yl]oxy-benzoic acid; 3,4-dihydroxy-5-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[(3,4,5-trihydroxybenzoyl)oxymethyl]oxan-2-yl]oxybenzoic acid; gallicacid-3-o-(6'-o-galloyl)glucoside; 3,4-dihydroxy-5-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[(3,4,5-trihydroxyphenyl)carbonyloxymethyl]oxan-2-yl]oxy-benzoic acid; gallic acid-3-o-(6'-o-galloyl)-glucoside | C20H20O14 | 484.36 | C1=C(C=C(C(=C1O)O)O)C(=O)OCC2C(C(C(C(O2)OC3=CC(=CC(=C3O)O)C(=O)O)O)O)O |
| TCMBANKIN058086 | phloroglucinol-3-O-β-D-glucopyranoside | phlorin | C12H16O8 | 288.25 g/mol | C1=C(C=C(C=C1O)OC2C(C(C(C(O2)CO)O)O)O)O |
| TCMBANKIN058100 | 2,3-o-(s)-hexahydroxydiphenoyl-d-gluco-pyranose | 2,3-hexahydroxydiphenyl-D-glucose | C20H18O14 | 482.3 g/mol | C1=C2C(=C(C(=C1O)O)O)C3=C(C(=C(C=C3C(=O)OC4C(C(C(OC4O)CO)O)OC2=O)O)O)O |
| TCMBANKIN058382 | 1-hydroxy-2-hydroxymethylanthraquinone | BRN 2218948; 9,10-Anthracenedione, 1-hydroxy-2-(hydroxymethyl)-; 1-Hydroxy-2-hydroxymethylanthraquinone; 1-Hydroxy-2-(hydroxymethyl)-9,10-anthracenedione; 9,10-Anthracenedione, 1-hydroxy-2-(hydroxymethyl)- (9CI); Digiferrugineol; 1-hydroxy-2-(hydroxymethyl)anthracene-9,10-dione; ANTHRAQUINONE, 1-HYDROXY-2-HYDROXYMETHYL-; 1-hydroxy-2-methylol-9,10-anthraquinone; C10327; 4-08-00-03278 (Beilstein Handbook Reference); Digiferruginol; 24094-45-9;1-Hydroxy-2-hydroxymethylanthraquinone; MolPort-039-338-647; 24094-45-9; Deoxylucidin; CHEBI:4544; BG00960207; CHEMBL495276; BRN 2218948; 1-Hydroxy-2-(hydroxymethyl)-9,10-anthracenedione; 1-hydroxy-2-(hydroxymethyl)anthracene-9,10-dione; ANTHRAQUINONE, 1-HYDROXY-2-HYDROXYMETHYL-; C10327; ACM24094459; 9,10-Anthracenedione, 1-hydroxy-2-(hydroxymethyl)- (9CI); 1-Hydroxy-2-(hydroxymethyl)anthra-9,10-quinone #; AC1L1N7Z; DTXSID40178818; 9,10-Anthracenedione, 1-hydroxy-2-(hydroxymethyl)-; Digiferrugineol; ZINC4098663; 4-08-00-03278 (Beilstein Handbook Reference); Digiferruginol; LS-20690; JCZCSQSSSAHDCB-UHFFFAOYSA-N;Deoxylucidin;digiferrugineol | C15H10O4 | 254.24 | C1=CC=C2C(=C1)C(=O)C3=C(C2=O)C(=C(C=C3)CO)O |
| TCMBANKIN058509 | prodelphinidin b2 | gallocatechin-(4α→8)-epigallocatechin; prodelphinidin b1 | C30H26O14 | 610.5 g/mol | C1C(C(OC2=C1C(=CC(=C2C3C(C(OC4=CC(=CC(=C34)O)O)C5=CC(=C(C(=C5)O)O)O)O)O)O)C6=CC(=C(C(=C6)O)O)O)O |
| TCMBANKIN058518 | epigallocatechin | Spectrum5_000889; (2S,3R)-2-(3,4,5-Trihydroxyphenyl)-chroman-3,5,7-triol; 08108_FLUKA; KBio2_003854; KBioSS_001286; epi-Gallocatechin; (−)-Epigallocatechin; SPBio_000885; Epigallocatechol; (2S,3S)-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-chromene-3,5,7-triol; AIDS-001348; Spectrum_000806; NCI60_026204; BCBcMAP01_000207; (2S,3S)-(+)-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-chromene-3,5,7-triol; MCULE-9338438267; CCRIS 5441; CHEBI:42255; Spectrum4_000950; 136892-45-0; (2R,3R)-2-(3,4,5-trihydroxyphenyl)chroman-3,5,7-triol; (3,3',4',5,5',7-Hexahydroxyflavan); (−)-cis-2-(3,4,5-Trihydroxyphenyl)-3,4-dihydro-1(2H)-benzopyran-3,5,7-triol; SCHEMBL1972938; (+)-epigallocatechin; AIDS001348; KBio3_001136; SDCCGMLS-0066479.P001; EGC; 1-epi-3',4',5,5',7-Pentahydroxy-3-Flavan; NSC674039; 2H-1-Benzopyran-3,5,7-triol, 3,4-dihydro-2-(3,4,5-trihydroxyphenyl)-, (2R-cis)- (9CI); 970-74-1; E3768_SIAL; EPIGALLOCATECHIN; C12136; 2H-1-Benzopyran-3,5,7-triol, 3,4-dihydro-2-(3,4,5-trihydroxyphenyl)-, (2R-cis)-; KBio2_006422; Antiscurvy factor C2; NCGC00180795-01; SpecPlus_000269; Factor C2 (antiscurvy); (-)cis-2-(3,4,5-Trihydroxyphenyl)-3,4-dihydro-2H-1-benzopyran-3,5,7-triol; (-)-3,3',4',5,5',7-Flavanhexol; 98032-84-9; l-Epigallocatechol; MolPort-001-740-311; 3,3',4',5,5',7-Flavanhexol; BSPBio_001636; (-)-Epigallocatechol; (2S,3S)-2-(3,4,5-Trihydroxy-phenyl)-chroman-3,5,7-triol; (-)-Epigallocatechin; (2R,3R)-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-chromene-3,5,7-triol; 3BC1BF1C-D95B-4EB2-943E-C1F59C7501A0; KBio1_001309; (2S,3S)-epigallocatechin; KBioGR_001540; SPECTRUM205113; ZINC3870339; CHEBI:71227; (2S,3S)-flavan-3,3',4',5,5',7-hexol; CHEMBL130415; (+)-epi-gallocatechin; NP-000358; Spectrum3_000248; (−)-cis-3,3′,4′,5,5′,7-Hexahydroxyflavane; 2-(3,4,5-TRIHYDROXY-PHENYL)-CHROMAN-3,5,7-TRIOL; (+)-cis-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-1(2H)-benzopyran-3,5,7-triol; Antiscurvy factor C(sub 2); 2545-09-7; ACon1_000192; SMP1_000114; KBio2_001286; L-Epigallocatechin; DivK1c_006365; (2S,3S)-2-(3,4,5-TRIHYDROXYPHENYL)-3,4-DIHYDRO-2H-1-BENZOPYRAN-3,5,7-TRIOL; Spectrum2_000703; (+)-cis-3,3',4',5,5',7-hexahydroxyflavane; BDBM50135171; (2S,3S)-flavan-3,5,7,3',4',5'-hexol;l-epigallocatechin | C15H14O7 | 306.27 | C1C(C(OC2=CC(=CC(=C21)O)O)C3=CC(=C(C(=C3)O)O)O)O |
| TCMBANKIN058523 | (?)-epiafzelechin | C15H14O5 | C1C(C(OC2=CC(=CC(=C21)O)O)C3=CC=C(C=C3)O)O | ||
| TCMBANKIN058556 | punicafolin | C41H30O26 | 938.66 | C1C2C(C(C(C(O2)OC(=O)C3=CC(=C(C(=C3)O)O)O)OC(=O)C4=CC(=C(C(=C4)O)O)O)OC(=O)C5=CC(=C(C(=C5C6=C(C(=C(C=C6C(=O)O1)O)O)O)O)O)O)OC(=O)C7=CC(=C(C(=C7)O)O)O | |
| TCMBANKIN058704 | lupeol | AC-1371; AKOS015960466; SCHEMBL14067725; 4CN-0933; C08628; BC201808; Lup-20(29)-en-3.beta.-ol; NSC90487; ZINC04081455; D0RA6H; Lupeol; LMPR01060013; lupeol ; Monogynol B; .beta.-Viscol; NCI60_042005; lup-20(29)-en-3beta-ol; Lupenol | C30H50O | 426.7 g/mol | CC(=C)C1CCC2(C1C3CCC4C5(CCC(C(C5CCC4(C3(CC2)C)C)(C)C)O)C)C |
| TCMBANKIN059515 | α-teresantalicacid | 166.22 g/mol | CC1(C2CC3C1(C3C2)C)C(=O)O | ||
| TCMBANKIN061392 | mucicacid 6-methyl ester 2-o-gallate | mucicacid 1-methyl ester 2-o-gallate | C14H16O12 | COC(=O)C(C(C(C(C(=O)O)OC(=O)C1=CC(=C(C(=C1)O)O)O)O)O)O | |
| TCMBANKIN061906 | 1-o-galloyl-glucose | C13H16O10 | 332.26 g/mol | COC1C(C(C(C(O1)OC(=O)C2=CC(=C(C(=C2)O)O)O)O)O)O |
植物对应的疾病
| 疾病ID | 病名 | 疾病类型 | MeSH | 参考文献 |
|---|
植物对应的靶点
| 靶点ID | 基因名 | 基因别名 | 描述 | 染色体位置 | Map_Location | 基因类型 |
|---|
滇ICP备16009434号-1 |
Dai SX Lab